RESUMEN
Previous studies have highlighted the importance of lung-draining lymph nodes in the respiratory allergic immune response, whereas the lung parenchymal immune system has been largely neglected. We describe a new in vivo model of respiratory sensitization to Blomia tropicalis, the principal asthma allergen in the tropics, in which the immune response is focused on the lung parenchyma by transfer of Th2 cells from a novel TCR transgenic mouse, specific for the major B. tropicalis allergen Blo t 5, that targets the lung rather than the draining lymph nodes. Transfer of highly polarized transgenic CD4 effector Th2 cells, termed BT-II, followed by repeated inhalation of Blo t 5 expands these cells in the lung >100-fold, and subsequent Blo t 5 challenge induced decreased body temperature, reduction in movement, and a fall in specific lung compliance unseen in conventional mouse asthma models following a physiological allergen challenge. These mice exhibit lung eosinophilia; smooth muscle cell, collagen, and goblet cell hyperplasia; hyper IgE syndrome; mucus plugging; and extensive inducible BALT. In addition, there is a fall in total lung volume and forced expiratory volume at 100 ms. These pathophysiological changes were substantially reduced and, in some cases, completely abolished by administration of neutralizing mAbs specific for IL-4 and IL-13 on weeks 1, 2, and 3. This IL-4/IL-13-dependent inducible BALT model will be useful for investigating the pathophysiological mechanisms that underlie asthma and the development of more effective drugs for treating severe asthma.
Asunto(s)
Acaridae/inmunología , Alérgenos/inmunología , Asma/inmunología , Interleucina-13/inmunología , Interleucina-4/inmunología , Pulmón/inmunología , Tejido Linfoide/inmunología , Células Th2/inmunología , Traslado Adoptivo , Alérgenos/administración & dosificación , Animales , Asma/fisiopatología , Hiperreactividad Bronquial/inmunología , Hiperreactividad Bronquial/fisiopatología , Líquido del Lavado Bronquioalveolar/inmunología , Linfocitos T CD4-Positivos/inmunología , Modelos Animales de Enfermedad , Inmunoglobulina E , Interleucina-13/administración & dosificación , Interleucina-4/administración & dosificación , Pulmón/citología , Pulmón/patología , Ganglios Linfáticos/inmunología , Ratones , Ratones Transgénicos , Eosinofilia Pulmonar/inmunología , Receptores de Antígenos de Linfocitos T/inmunologíaRESUMEN
BACKGROUND: Eczema is a known risk factor for the development of wheeze in childhood. Cord blood T-cell cytokine responses have been shown to be associated with the development of both early childhood eczema and wheeze. Our objective is to study and compare the influence of intrinsic T-cell cytokine responses on the development of wheezing and eczema in the first 2 years of life in a birth cohort of at risk (first degree family with atopic disease) infants. METHODS: Cord blood samples were collected from 195 eligible subjects of a birth cohort of 253 subjects. The subjects studied were those who developed either wheezing (n = 34) or eczema (n = 29) in the first 2 years of life, and 65 healthy infants served as control. Cytokines from phytohaemagglutinin stimulated mononuclear cells were analyzed using multiplex cytokine assays and the cytokine profiles in the 3 groups were compared. RESULTS: Most of the subjects were non-atopic with only 3/34 (9%) wheeze and 9/29 (31%) eczema subjects sensitized to the common dietary or inhalant allergens. After adjustment for potential risk factors, wheeze, but not eczema subjects, presented with hyper-responsive cytokine profiles with increased production of T-cell cytokines IL-2 and IL-5. IL-5 was the strongest risk factor associated to the development of wheeze at 2 years of age (OR, 35; 95% CI, 5.0 -246.7). CONCLUSION: Cord blood cytokine responses in early onset wheeze and eczema are distinctly different. This suggests that the tendency to develop early onset wheeze may be influenced by preexisting immune factors independent to those for eczema.
Asunto(s)
Eccema/inmunología , Hipersensibilidad Inmediata/inmunología , Interleucina-2/inmunología , Interleucina-5/inmunología , Ruidos Respiratorios/etiología , Ruidos Respiratorios/inmunología , Linfocitos T/inmunología , Preescolar , Eccema/etiología , Sangre Fetal/inmunología , Humanos , Lactante , Factores de RiesgoRESUMEN
Der p 2, a major allergen of Dermatophagoides pteronyssinus mites, is one of the most clinically relevant allergens to allergic patients worldwide. FIP-fve protein (Fve) from the golden needle mushroom (Flammulina velutipes) is an immunomodulatory protein with potential Th1-skewed adjuvant properties. Here, we produced and immunologically evaluated a Der p 2-Fve fusion protein as a potential immunotherapeutic for allergic diseases. Using an inducible expression system in cultured rice suspension cells, the recombinant Der p 2-Fve fusion protein (designated as OsDp2Fve) was expressed in rice cells under the control of an α-amylase gene (αAmy8) promoter and secreted under sucrose starvation. OsDp2Fve was partially purified from the cultured medium. The conformation of Der p 2 in OsDp2Fve remains intact as reflected by its unaltered allergenicity, as assessed by human IgE ELISA and histamine release assays, compared to non-fusion Der p 2 protein. Furthermore, the Fve protein expressed in OsDp2Fve retains its in vitro lymphoproliferative activity but loses its hemagglutination and lymphoagglutination effects compared to the native protein. Notably, in vivo evaluation showed that mice administered with OsDp2Fve possessed an enhanced production of Der p 2-specific IgG antibodies without potentiating the production of Der p 2-specific IgE and Th2 effector cytokines in comparison with mice co-administered with native Fve and Der p 2 proteins. These results suggest that the recombinant Der p 2-Fve fusion protein produced in rice suspension cell cultures has a great potential for allergy immunotherapy.
Asunto(s)
Antígenos Dermatofagoides/genética , Proteínas de Artrópodos/genética , Proteínas Fúngicas/genética , Factores Inmunológicos/genética , Oryza/genética , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/inmunología , Animales , Antígenos Dermatofagoides/inmunología , Proteínas de Artrópodos/inmunología , Sangre/efectos de los fármacos , Sangre/metabolismo , Técnicas de Cultivo de Célula/métodos , Medios de Cultivo/metabolismo , Citocinas/metabolismo , Ensayo de Inmunoadsorción Enzimática , Proteínas Fúngicas/inmunología , Pruebas de Hemaglutinación , Histamina/metabolismo , Humanos , Inmunoglobulina G , Factores Inmunológicos/metabolismo , Ratones , Ratones Endogámicos C57BL , Oryza/citología , Plantas Modificadas Genéticamente , Regiones Promotoras Genéticas , Proteínas Recombinantes de Fusión/metabolismo , Proteínas Recombinantes de Fusión/farmacología , Células Th2/inmunología , Células Th2/metabolismo , alfa-Amilasas/genéticaRESUMEN
BACKGROUND: Studies have suggested that demographic and lifestyle factors could shape the composition of fecal microbiota in early life. This study evaluated infant stool microbiota signatures in two Asian populations, Singapore (n = 42) and Indonesia (n = 32) with contrasting socioeconomic development, and examined the putative influences of demographic factors on these human fecal associated bacterial signatures. RESULTS: Longitudinal analysis showed associations of geographical origin with Clostridium leptum, Atopobium and Bifidobacterium groups. Mode of delivery had the largest effect on stool microbiota signatures influencing the abundance of four bacterial groups. Significantly higher abundance of bacterial members belonging to the Bacteroides-Prevotella, Bifidobacterium and Atopobium groups, but lower abundance of Lactobacilli-Enterococci group members, were observed in vaginal delivered compared to caesarean delivered infants. Demographic factors influencing the structure of infants stool microbiota during the first year of life included breastfeeding, age of weaning, sibship size and exposure to antibiotics. CONCLUSIONS: Differences in stool microbiota signatures were observed in relation to various demographic factors. These features may confound studies relating to the association of the structure of fecal microbiota and the predisposition to human modern disease.
Asunto(s)
Biodiversidad , Heces/microbiología , Metagenoma , Humanos , Indonesia , Lactante , Recién Nacido , Estudios Longitudinales , Singapur , Factores SocioeconómicosRESUMEN
CD4(+) memory/effector T cells play a central role in orchestrating the rapid and robust immune responses upon re-encounter with specific Ags. However, the immunologic mechanism(s) underlying these responses are still not fully understood. To investigate this, we generated an allergen (major house dust mite allergen, Blo t 5)-specific murine Th2 cell line that secreted IL-4, IL-5, IL-10, and IL-13, but not IL-9 or TNF-α, upon activation by the cognate Ag. These cells also exhibited CD44(high)CD62L(-) and CD127(+) (IL-7Rα(+)) phenotypes, which are characteristics of memory/effector T cells. Experiments involving adoptive transfer of this Th2 cell line in mice, followed by three intranasal challenges with Blo t 5, induced a dexamethasone-sensitive eosinophilic airway inflammation. This was accompanied by elevation of Th2 cytokines and CC- and CXC-motif chemokines, as well as recruitment of lymphocytes and polymorphic mononuclear cells into the lungs. Moreover, Blo t 5-specific IgE was detected 4 d after the last intranasal challenge, whereas elevation of Blo t 5-specific IgG1 was found at week two. Finally, pulmonary delivery of the pVAX-IL-35 DNA construct effectively downregulated Blo t 5-specific allergic airway inflammation, and i.m. injection of pVAX-IL-35 led to long-lasting suppression of circulating Blo t 5-specific and total IgE. This model provides a robust research tool to elucidate the immunopathogenic role of memory/effector Th2 cells in allergic airway inflammation. Our results suggested that IL-35 could be a potential therapeutic target for allergic asthma through its attenuating effects on allergen-specific CD4(+) memory/effector Th2 cell-mediated airway inflammation.
Asunto(s)
Antígenos de Plantas/inmunología , Inmunoglobulina E/biosíntesis , Memoria Inmunológica , Mediadores de Inflamación/fisiología , Subunidad p35 de la Interleucina-12/fisiología , Pulmón/inmunología , Ácaros/inmunología , Células Th2/inmunología , Alérgenos , Animales , Línea Celular , Células Cultivadas , Polvo , Epítopos de Linfocito T/inmunología , Femenino , Inflamación/inmunología , Inflamación/metabolismo , Inflamación/patología , Pulmón/metabolismo , Pulmón/patología , Ratones , Ratones Endogámicos C57BL , Células Th2/metabolismo , Células Th2/patologíaRESUMEN
Group 1 allergen from Dermatophagoid pteronyssinus (Der p 1) belongs to the papain-like cysteine protease family and is a major cause of allergic rhinitis and asthma. An anti-Der p 1 monoclonal antibody, mAb W108, was selected and isolated from Der p-specific IgG2b-producing hybridoma clones. Two-dimensional electrophoresis and immunoblotting showed that mAb W108 reacted with four components of Der p extracts with a molecular mass of 35 kDa and pI values varying from 4 to 6; it also reacted with IgE antibodies in the sera of Der p-sensitive patients. In the competitive assay and using azocasein as a substrate, we found that mAb W108 inhibited not only the binding of Der p 1, but also its cysteine protease activity in a dose-dependent manner. The two peptide segments of Der p 1 identified by mAb W108 (aa 151-197 and 286-320) were parts of inter-connecting loops located in the substrate-binding cleft and on the surface of the domain comprising mainly ß-sheets. From the predicted interaction between the amino acid sequence in the CDR3 of mAb W108 and Der p 1-binding epitopes, the possible binding sites for mAb W108 to Der p 1 may sterically hinder the IgE epitope and the active site of cysteine protease activity. Administration of mAb W108 in the Der p-sensitized murine model of asthma alleviated allergen-induced airway inflammation and the Th2 cytokine immune response, suggesting its therapeutic potential. These findings can provide new insights into understanding IgE-mediated disease and the design of modified allergen vaccines for future allergen-specific immunotherapy.
Asunto(s)
Anticuerpos Monoclonales/química , Anticuerpos Monoclonales/inmunología , Antígenos Dermatofagoides/inmunología , Mapeo Epitopo , Secuencia de Aminoácidos , Animales , Anticuerpos Monoclonales/farmacología , Antígenos Dermatofagoides/química , Proteínas de Artrópodos , Asma/inmunología , Asma/metabolismo , Asma/patología , Sitios de Unión de Anticuerpos/inmunología , Cisteína Endopeptidasas , Modelos Animales de Enfermedad , Epítopos/química , Epítopos/inmunología , Femenino , Humanos , Inmunoglobulina E/inmunología , Cadenas Pesadas de Inmunoglobulina/química , Cadenas Pesadas de Inmunoglobulina/inmunología , Cadenas Ligeras de Inmunoglobulina/química , Cadenas Ligeras de Inmunoglobulina/inmunología , Inflamación/inmunología , Inflamación/metabolismo , Inflamación/patología , Ratones , Ratones Endogámicos BALB C , Modelos Moleculares , Datos de Secuencia Molecular , Péptido Hidrolasas/metabolismo , Unión Proteica/efectos de los fármacos , Unión Proteica/inmunología , Conformación Proteica , Proteómica , Sistema Respiratorio/inmunología , Sistema Respiratorio/metabolismo , Sistema Respiratorio/patologíaRESUMEN
Eczema is a chronic form of childhood disorder that is gaining in prevalence in affluent societies. Previous studies hypothesized that the development of eczema is correlated with changes in microbial profile and composition of early life endemic microbiota, but contradictory conclusions were obtained, possibly due to the lack of minimization of apparent non-health related confounders (e.g., age, antibiotic consumption, diet and mode of delivery). In this study, we recruited seven caesarean-delivered and total formula-fed infants, and comparatively examined the early-life endemic microbiota in these infants with and without eczema. Using 16S pyrosequencing, infants' fecal microbiota were observed to comprise Proteobacteria, Firmicutes, Actinobacteria and Bacteroidetes as the four main phyla, and the presence and absence of specific populations within these four phyla are primarily mediated by ageing. Quantitative analysis of bacterial targets on a larger sample size (n = 36 at 1, 3, and 12 months of age) revealed that the abundances of Bifidobacterium and Enterobacteriaceae were different among caesarean-delivered infants with and without eczema, and the bacterial targets may be potential biomarkers that can correlate to the health status of these infants. Our overall findings suggest that the minimization of possible confounders is essential prior to comparative evaluation and correlation of fecal microbiota to health status, and that stool samples collected from caesarean-delivered infants at less than 1 year of age may represent a good cohort to study for potential biomarkers that can distinguish infants with eczema from those without. These findings would greatly facilitate future efforts in understanding the possible pathogenesis behind certain bacterial targets, and may lead to a timely intervention that reduces the occurrence of early life eczema and possibly allergic disorders in later life.
Asunto(s)
Eccema/microbiología , Heces/microbiología , Metagenoma/genética , Factores de Edad , Bifidobacterium/aislamiento & purificación , Biomarcadores , Cesárea , Dermatoglifia del ADN , ADN Bacteriano/análisis , Enterobacteriaceae/aislamiento & purificación , Humanos , LactanteRESUMEN
Fve is a fungal protein isolated from the golden needle mushroom Flammulina velutipes and has previously been reported to trigger immunological responses in both mouse and human lymphocytes. In this study, we evaluated the potential application of Fve as an adjuvant for tumour immunotherapy and examined the underlying mechanism(s). When the human papillomavirus (HPV)-16 E7 oncoprotein was used as a model antigen, mice coimmunized with HPV-16 E7 and Fve showed enhanced production of HPV-16 E7-specific antibodies as well as expansion of HPV-16 E7-specific interferon (IFN)-gamma-producing CD4(+) and CD8(+) T cells as compared with mice immunized with HPV-16 E7 alone. Tumour protection assays showed that 60% of mice coimmunized with HPV-16 E7 plus Fve, as compared with 20% of those immunized only with HPV-16 E7, remained tumour-free for up to 167 days after challenge with the tumour cells. Tumour therapeutic assays showed that HPV-16 E7 plus Fve treatment significantly prolonged the survival of tumour-bearing mice as compared with those treated only with HPV-16 E7. In vivo cell depletion and adoptive T-cell transfer assays showed that CD4(+) and CD8(+) T cells and IFN-gamma played critical roles in conferring the antitumour effects. Interestingly, Fve could stimulate the maturation of splenic dendritic cells in vivo and induce antigen-specific CD8(+) T-cell immune responses. In summary, Fve has potent adjuvant properties that enhance T helper type 1 antigen-specific humoral and cellular immune responses which confer strong antitumour effects. The use of Fve as an adjuvant could be an attractive alternative to the current vaccination strategy for cancer immunotherapy.
Asunto(s)
Adyuvantes Inmunológicos/administración & dosificación , Flammulina/inmunología , Proteínas Fúngicas/administración & dosificación , Papillomavirus Humano 16 , Inmunoterapia Activa/métodos , Proteínas Oncogénicas Virales/administración & dosificación , Infecciones por Papillomavirus/terapia , Neoplasias del Cuello Uterino/terapia , Adyuvantes Inmunológicos/uso terapéutico , Animales , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD8-positivos/inmunología , Línea Celular Tumoral , Células Dendríticas/inmunología , Femenino , Proteínas Fúngicas/inmunología , Proteínas Fúngicas/uso terapéutico , Humanos , Interferón gamma/biosíntesis , Activación de Linfocitos , Ratones , Ratones Endogámicos C57BL , Proteínas Oncogénicas Virales/inmunología , Proteínas Oncogénicas Virales/uso terapéutico , Proteínas E7 de PapillomavirusRESUMEN
PURPOSE OF REVIEW: Antiallergy DNA vaccine is an attractive alternative for the prevention and treatment of allergic diseases. This review covers recent studies to enhance potency and safety of antiallergy DNA vaccines. RECENT FINDINGS: Dendritic cell-targeted allergen gene vaccination using fascin gene promoter inhibited IgE production and allergic inflammation but not airway hyperresponsiveness. Targeting allergen expression at immature dendritic cells or induction of tolerogenic dendritic cells could induce antiallergic T regulatory cells. Vaccination with DNA-encoded Ag85B and AIMP1 as adjuvants could downregulate established Th2-mediated allergic responses. Forced ubiquitation or targeting allergens to lysosomal/endosomal compartments could avoid risk of allergen sensitization. Gene gun delivery of conventional antiallergy DNA vaccine is a risk factor. Replicase-based allergy DNA vaccines showed enhanced immunogenecity and safety as compared to conventional DNA vaccines. TANK-binding kinase-1 (TBK1) is a novel key molecule in DNA vaccine-induced immunogenicity. SUMMARY: Dendritic cell-based approach has been actively explored to enhance immunogenicity of antiallergy DNA vaccines. Codelivery of hypoallergenic DNA vaccines with potent adjuvants via a desirable delivery mode will help to fulfill the requirements for clinical application of antiallergy DNA vaccines. Activation of TBK1 signaling pathway could be a novel strategy to enhance immunogenicity of DNA vaccines.
Asunto(s)
Alérgenos/inmunología , Hipersensibilidad/terapia , Vacunas de ADN/uso terapéutico , Adyuvantes Inmunológicos , Alérgenos/genética , Animales , Células Dendríticas/inmunología , Humanos , Hipersensibilidad/prevención & control , Proteínas Serina-Treonina Quinasas/inmunología , Replicón/inmunología , Vacunas de ADN/inmunologíaRESUMEN
The Bifidobacterium spp. present in 10 infant fecal samples (4 from infants with eczema and 6 from healthy infants) were quantified with both hierarchical oligonucleotide primer extension (HOPE) and fluorescence in situ hybridization-flow cytometry. The relative abundances of Bifidobacterium longum and B. catenulatum with respect to the total bifidobacteria had a poor correlation (rho, <0.600; P value, >0.208), presumably due to differences in primer specificity and the level of hybridization stringency of both methods. In contrast, the relative abundances of organisms of the genus Bifidobacterium against the total amplified 16S rRNA genes and those of B. adolescentis, B. bifidum, and B. breve against the genus Bifidobacterium exhibited a good statistical correlation (rho, >0.783; P value, <0.066). This good comparability supports HOPE as a method to achieve high-throughput quantitative determination of bacterial targets in a time- and cost-effective manner.
Asunto(s)
Bifidobacterium/aislamiento & purificación , Recuento de Colonia Microbiana/métodos , Cartilla de ADN/genética , Heces/microbiología , Bifidobacterium/genética , Citometría de Flujo/métodos , Humanos , Hibridación Fluorescente in Situ/métodos , Lactante , ARN Bacteriano/genética , ARN Ribosómico 16S/genética , Factores de TiempoRESUMEN
AIMS: Bifunctional apoptosis regulator (BAR) is an endoplasmic reticulum protein that interacts with both the extrinsic and intrinsic apoptosis pathways. We hypothesize that over-expression of BAR Delta RING prevents apoptosis and injury following ischaemia/reperfusion (I/R) and attenuates doxorubicin (DOX)-induced cardiotoxicity. METHODS AND RESULTS: We generated a line of transgenic mice that carried a human BAR Delta RING transgene under the control of the mouse alpha-myosin heavy chain promoter. The RING domain, which binds ubiquitin conjugating enzymes, was deleted to prevent auto-ubiquitination of BAR and allow accumulation of the BAR protein, which binds apoptosis-regulating proteins. High levels of human BAR Delta RING transcripts and 42 KDa BAR Delta RING protein were expressed in the hearts of transgenic mice. When excised hearts were reperfused ex vivo for 45 min as Langendorff preparations after 45 min of global ischaemia, the functional recovery of the hearts, expressed as left ventricular developed pressure x heart rate, was 23 +/- 1.7% in the non-transgenic hearts compared with 51.5 +/- 4.3% in the transgenic hearts (P < 0.05). For in vivo studies, mice were subjected to 50 min of ligation of the left descending anterior coronary artery followed by 4 h of reperfusion. The infarct sizes following I/R injury, expressed as the percentage of the area at risk, were significantly smaller in the transgenic mice than in the non-transgenic mice (29 +/- 4 vs. 55 +/- 4%, P < 0.05). In hearts of mice subjected to cardiac I/R injury, BAR transgenic hearts had significantly fewer in situ oligo-ligation-positive cardiac cells (5.0 +/- 0.4 vs. 13.4 +/- 0.5%, P < 0.05). Over-expression of BAR Delta RING also significantly attenuated DOX-induced cardiac dysfunction and apoptosis. CONCLUSION: Our results demonstrate that over-expression of BAR Delta RING renders the heart more resistant to I/R injury and DOX-induced cardiotoxicity, and this protection correlates with reduced cardiomyocyte apoptosis.
Asunto(s)
Proteínas Adaptadoras Transductoras de Señales/metabolismo , Antibióticos Antineoplásicos/efectos adversos , Proteínas Reguladoras de la Apoptosis/metabolismo , Doxorrubicina/efectos adversos , Cardiopatías/inducido químicamente , Cardiopatías/prevención & control , Proteínas de la Membrana/metabolismo , Daño por Reperfusión Miocárdica/prevención & control , Proteínas Adaptadoras Transductoras de Señales/genética , Animales , Antibióticos Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Apoptosis/fisiología , Proteínas Reguladoras de la Apoptosis/genética , Calcio/metabolismo , Modelos Animales de Enfermedad , Doxorrubicina/farmacología , Cardiopatías/metabolismo , Humanos , Proteínas de la Membrana/genética , Ratones , Ratones Transgénicos , Infarto del Miocardio/patología , Infarto del Miocardio/prevención & control , Daño por Reperfusión Miocárdica/metabolismo , Daño por Reperfusión Miocárdica/fisiopatología , Miocardio/metabolismo , Miocardio/patología , Complejo de la Endopetidasa Proteasomal/metabolismo , Dominios RING Finger/genética , Ubiquitina/metabolismoRESUMEN
BACKGROUND: Blomia tropicalis is an important domestic dust mite in the tropics and subtropics. This study describes cDNA cloning of the group 4 allergen of B. tropicalis, and the evaluation of the sensitization of this allergen in atopic populations from 2 geographic regions. METHODS: cDNA cloning was carried out using the Smart RACE cDNA amplification kit. The full-length Blo t 4 cDNA was isolated by cDNA library screening, 5' and 3' rapid amplification of cDNA ends and long-distance PCR. Sequence analysis was performed with a combination of the Clustal W, CGC and Blast program packages. The cDNA was expressed in Pichia pastoris yeast. The skin prick test was used to evaluate the sensitization profile of recombinant Blo t 4, crude dust mite allergen extracts and major B. tropicalis recombinant allergen Blo t 5. RESULTS: The cloned Blo t 4 had a molecular weight of 56 kDa and had 68% amino acid homology with group 4 allergens of Dermatophagoides pteronyssinus and 65% with those of Euroglyphus maynei. A sensitization profile to the expressed recombinant Blo t 4 allergen (28%) showed an unusually higher frequency than to the major allergen Blo t 5 (22%) in allergic subjects from Chengdu, PR China. In comparison, the subjects from Singapore showed very low sensitization to Blo t 4 (4%) compared with Blo t 5 (84%). CONCLUSIONS: Group 4 allergens of B. tropicalis may be an important dust mite allergen in certain distinct populations.
Asunto(s)
Alérgenos/inmunología , Hipersensibilidad/inmunología , Ácaros/inmunología , alfa-Amilasas/inmunología , Adolescente , Adulto , Alérgenos/metabolismo , Secuencia de Aminoácidos , Animales , Antígenos de Plantas , Secuencia de Bases , Niño , Preescolar , China/epidemiología , Clonación Molecular , Humanos , Hipersensibilidad/epidemiología , Persona de Mediana Edad , Ácaros/enzimología , Datos de Secuencia Molecular , Proteínas Recombinantes/genética , Proteínas Recombinantes/inmunología , Alineación de Secuencia , Singapur/epidemiología , Pruebas Cutáneas , Adulto Joven , alfa-Amilasas/genéticaRESUMEN
BACKGROUND: Probiotics are used as a management strategy for allergic diseases, but their effects on allergic responses in sensitized allergic individuals remain unclear. This study explored the immunomodulatory effects of probiotics on allergen-specific allergic reactions in an allergy mouse model. METHODS: C57BL/6 mice were presensitized by epicutaneous patching with recombinant Der p 2, and were subsequently administered orally with either heat-killed wild-type Lactobacillus casei or NaHCO(3) buffer for 5 weeks (n=6 per group). All mice then received 2 subcutaneous immunizations of Der p 2 to mimic allergen immunotherapy, followed by aerosol challenge with Der p 2 a week later. RESULTS: The Der p 2-sensitized mice fed L. casei showed significantly lower Der p 2-specific IgE and IgG1 after subcutaneous immunizations and airway challenge with Der p 2 compared to the control, unfed group. Splenic T cells of mice fed L. casei showed suppression of Th-2 (IL-5, IL-13, IL-10 and IL-4) and proinflammatory (TNF-alpha, IFN-gamma) cytokines. Following airway allergen challenge, the mice fed L. casei showed histological evidence of attenuation of lung inflammation, as well as reductions in the total cell count and Th2 and proinflammatory cytokines in bronchoalveolar lavage fluid, compared to controls. Taken together, these results suggest that the oral administration of heat-killed L. casei could effectively downregulate the pre-existing Th-2 allergic responses and pulmonary inflammatory responses upon subcutaneous and airway allergen challenge. CONCLUSIONS: L. casei has intrinsic adjuvant and immunomodulatory properties that could potentially be exploited for secondary prevention or treatment of allergic respiratory diseases.
Asunto(s)
Antígenos Dermatofagoides/inmunología , Factores Inmunológicos/uso terapéutico , Lacticaseibacillus casei , Probióticos/uso terapéutico , Hipersensibilidad Respiratoria/terapia , Animales , Antígenos Dermatofagoides/administración & dosificación , Proteínas de Artrópodos , Líquido del Lavado Bronquioalveolar/química , Líquido del Lavado Bronquioalveolar/citología , Recuento de Células , Citocinas/metabolismo , Modelos Animales de Enfermedad , Inmunización , Inmunoglobulina E/sangre , Inmunoglobulina E/inmunología , Inmunoglobulina G/sangre , Inmunoglobulina G/inmunología , Factores Inmunológicos/farmacología , Leucocitos/citología , Pulmón/efectos de los fármacos , Pulmón/patología , Ganglios Linfáticos/citología , Ganglios Linfáticos/inmunología , Linfocitos/efectos de los fármacos , Linfocitos/inmunología , Linfocitos/metabolismo , Ratones , Ratones Endogámicos C57BL , Probióticos/farmacología , Hipersensibilidad Respiratoria/inmunología , Bazo/citología , Bazo/inmunología , Linfocitos T/efectos de los fármacos , Linfocitos T/inmunología , Linfocitos T/metabolismoRESUMEN
DNA immunization with in vivo electroporation is an efficient alternative protocol for the production of monoclonal antibodies (mAb). Generation of mAb by DNA immunization is a novel approach to circumvent the following technical hurdles associated with problematic antigens: low abundance and protein instability and use of recombinant proteins that lack posttranslational modifications. This chapter describes the use of a DNA-based immunization protocol for the production of mAb against a house dust mite allergen, designated as Blo t 11, which is a paramyosin homologue found in Blomia tropicalis mites. The Blo t 11 cDNA fused at the N terminus to the sequence of a signal peptide was cloned into the pCI mammalian expression vector. The DNA construct was injected intramuscularly with in vivo electroporation into mice, and the specific antibody production in mice was analyzed by enzyme-linked immunosorbent assay (ELISA). Hybridomas were generated by fusing mouse splenocytes with myeloma cells using the ClonaCell-HY Hybridoma Cloning Kit. Six hybridoma clones secreting Blo t 11 mAb were successfully generated, and these mAb are useful reagents for immunoaffinity purification and immunoassays.
Asunto(s)
Anticuerpos Monoclonales/biosíntesis , Electroporación/métodos , Vacunas de ADN/administración & dosificación , Alérgenos/genética , Alérgenos/inmunología , Animales , Antígenos de Plantas , Secuencia de Bases , Cartilla de ADN/genética , Femenino , Hibridomas/inmunología , Inmunización/métodos , Inyecciones Intramusculares , Ratones , Ratones Endogámicos BALB C , Ácaros/genética , Ácaros/inmunología , Vacunas de ADN/genéticaRESUMEN
Lipopolysaccharide (LPS) is a major component of environmental microbial products. Studies have defined the LPS dose as a critical determining factor in driving differential T-cell polarization but the direct effects of LPS on individual antigen-presenting cells is unknown. Here, we investigated the effects of LPS doses on naive B cells and the subsequent modulatory effects of these LPS-activated B cells on T-cell polarization. The LPS was able to induce a proliferative response starting at a dose of 100 ng/ml and was capable of enhancing antigen internalization at a dose of 1 microg/ml in naive B cells. Following LPS stimulation, up-regulation of the surface markers CD40, CD86, I-Ad, immunoglobulin M, CD54 and interleukin-10 production, accompanied by down-regulation of CD5 and CD184 (CXCR4) were observed in a LPS dose-dependent manner. Low doses (<10 ng/ml) of LPS-activated B cells drove T helper type 2 polarization whereas high doses (>0.1 microg/ml) of LPS-activated B cells resulted in T regulatory type 1 cell polarization. In conclusion, LPS-activated B cells acquire differential modulatory effects on T-cell polarization. Such modulatory effects of B cells are dependent on the stimulation with LPS in a dose-dependent manner. These observations may provide one of the mechanistic explanations for the influence of environmental microbes on the development of allergic diseases.
Asunto(s)
Linfocitos B/inmunología , Lipopolisacáridos/inmunología , Cooperación Linfocítica/inmunología , Linfocitos T/inmunología , Animales , Antígenos de Superficie/metabolismo , Polaridad Celular/inmunología , Proliferación Celular , Células Cultivadas , Relación Dosis-Respuesta Inmunológica , Endocitosis/inmunología , Interleucina-10/biosíntesis , Lectinas Tipo C/inmunología , Activación de Linfocitos/inmunología , Receptor de Manosa , Lectinas de Unión a Manosa/inmunología , Ratones , Ratones Endogámicos BALB C , Ratones Transgénicos , Pinocitosis , Receptores de Superficie Celular/inmunología , Bazo/inmunología , Regulación hacia Arriba/inmunologíaRESUMEN
Blo t 5 is the major allergen from Blomia tropicalis mites and shows strong IgE reactivity with up to 90% of asthmatic and rhinitis patients' sera. The NMR solution structure of Blo t 5 comprises three long alpha helices, forming a coiled-coil, triple-helical bundle with a left-handed twist. TROSY-NMR experiments were used to study Blo t 5 interaction with the Fab' of a specific monoclonal antibody, mAb 4A7. The mAb epitope comprises two closely spaced surfaces, I and II, connected by a sharp turn and bearing critical residues Asn46 and Lys47 on one surface, and Lys54 and Arg57 on the other. This discontinuous epitope overlaps with the human IgE epitope(s) of Blo t 5. Epitope surface II is further predicted to undergo conformational exchange in the millisecond to microsecond range. The results presented are critical for the design of a hypoallergenic Blo t 5 for efficacious immunotherapy of allergic diseases.
Asunto(s)
Alérgenos/química , Alérgenos/inmunología , Proteínas de Insectos/química , Ácaros/inmunología , Secuencia de Aminoácidos , Animales , Sitios de Unión de Anticuerpos , Secuencia Conservada , Epítopos/análisis , Epítopos/química , Inmunoglobulina E/química , Proteínas de Insectos/inmunología , Espectroscopía de Resonancia Magnética , Modelos Moleculares , Datos de Secuencia Molecular , Conformación ProteicaRESUMEN
Fish allergy is common in countries where consumption is high. Asian nations are amongst the world's largest consumers of fish but the allergen profiles of tropical fish are unknown. This study sought to evaluate the allergenicity of four commonly consumed tropical fish, the threadfin (Polynemus indicus), Indian anchovy (Stolephorus indicus), pomfret (Pampus chinensis) and tengirri (Scomberomorus guttatus). Immunoglobulin E (IgE) cross-reactivity with parvalbumin of cod fish (Gad c 1), the major fish allergen, was also studied. Detection of tropical fish and cod specific-IgE was performed by UniCap assay, and skin prick tests were also carried out. The IgE-binding components of tropical fish were identified using IgE immunoblot techniques, and cross-reactivity with Gad c 1 was assessed by ELISA inhibition and IgE immunoblot inhibition. Clinically, nine of 10 patients studied were allergic to multiple fish. All patients exhibited detectable specific-IgE to cod fish (10 of 10 skin prick test positive, eight of 10 UniCap assay positive) despite lack of previous exposure. The major allergen of the four tropical fish was the 12-kDa parvalbumin. IgE cross-reactivity of these allergens to Gad c 1 was observed to be moderate to high in the tropical fish studied. Parvalbumins are the major allergens in commonly consumed tropical fish. They are cross-reactive with each other as well as with Gad c 1. Commercial tests for cod fish appear to be sufficient for the detection of tropical fish specific-IgE.
Asunto(s)
Alérgenos/efectos adversos , Productos Pesqueros/efectos adversos , Proteínas de Peces/inmunología , Hipersensibilidad a los Alimentos/inmunología , Gadiformes , Parvalbúminas/inmunología , Adulto , Alérgenos/sangre , Alérgenos/inmunología , Animales , Niño , Reacciones Cruzadas/inmunología , Ensayo de Inmunoadsorción Enzimática , Femenino , Proteínas de Peces/efectos adversos , Proteínas de Peces/sangre , Hipersensibilidad a los Alimentos/sangre , Hipersensibilidad a los Alimentos/fisiopatología , Humanos , Inmunoglobulina E/sangre , Inmunoglobulina E/inmunología , Masculino , Parvalbúminas/efectos adversos , Parvalbúminas/sangreRESUMEN
BACKGROUND: An imbalanced prevalence of allergic diseases occurs in the region of South East Asia. It has been suggested that a change in lifestyle associated with improved hygiene and modernization has altered the composition of human gastrointestinal microbiota, and hence susceptibility to allergy. METHODS: This cross-sectional study was designed to investigate the differences between fecal microbiota in children living in areas with contrasting socioeconomic development. Fecal samples from 73 young children (age 3.0 +/- 0.5) from rural Thailand and 69 age-matched children from urban Singapore were collected and studied using selective culture. Clinical data were also collected using modified ISAAC questionnaires, aiming to identify the key differences in the demographic as well as clinical features between the two study groups. RESULTS: The two contrasting populations studied differed significantly in multiple lifestyle factors such as family size, antibiotic use and sources of drinking water in the households. Rural children harbored significantly higher counts of lactic acid bacteria (LAB) [7.1 (6.4, 8.3) vs 6.0 (5.3, 7.0) logCFU/g, p < 0.001)], coliforms [8.9 (7.3, 10.2) vs 6.9 (5.7, 7.7) logCFU/g, p < 0.001)] as well as staphylococci [5.3 (4.8, 6.3) vs 4.3 (3.6, 5.0) logCFU/g, p < 0.001)] than their urban counterparts. However, enterococcal counts did not differ between the two groups. No single lifestyle factor could be identified to have caused such differences. CONCLUSIONS: Certain fecal microbial counts were higher in rural children compared with urban children in South East Asia. Several contrasting home environmental conditions and practices were also identified. These may serve as a basis for future investigation of lifestyle factors underlying the global gradient of the increasing trends of allergic diseases.
Asunto(s)
Tracto Gastrointestinal/microbiología , Hipersensibilidad/epidemiología , Hipersensibilidad/microbiología , Bacteroides , Preescolar , Recuento de Colonia Microbiana , Susceptibilidad a Enfermedades , Heces/enzimología , Heces/microbiología , Femenino , Humanos , Hipersensibilidad/enzimología , Hipersensibilidad/inmunología , Estilo de Vida , Masculino , Población Rural , Singapur , Factores Socioeconómicos , Encuestas y Cuestionarios , Tailandia , Población UrbanaRESUMEN
The fecal microbiota of 37 infants with (n = 20) or without (n = 17) probiotic administration was evaluated on D 3, and at 1, 3, and 12 mo by fluorescence in situ hybridization-flow cytometry (FISH-FC), PCR, and bacteriological culture methods. They represent consecutive subjects of an ongoing double-blind, placebo-controlled trial on a probiotic formula (LGG and Bifidobacterium longum) administered during the first 6 mo of life. Despite varying composition in each baby, there was a general bacterial colonization pattern in the first year. Bifidobacteria increased markedly (p = 0.0003) with a parallel decrease in Enterobacteriaceae (p < 0.001) and Bacteroides-Prevotella (p = 0.005) populations. Eubacterium rectale-Clostridium coccoides (p < 0.001) and Atopobium (p = 0.039) groups also gradually increased. This overall pattern was unaffected by probiotic administration (p > 0.05). B. longum (p = 0.005) and Lactobacillus rhamnosus (p < 0.001) were detected more frequently in probiotic group during supplementation, but no difference after supplementation had ceased (p > 0.05). Cultured lactic acid bacteria were also more numerous in the probiotic-administered babies during treatment period (log CFU/g 8.4 versus 7.4; p = 0.035). Our results indicate that supplemented strains could be detected but did not persist in the bowel once probiotic administration had ceased.
Asunto(s)
Pueblo Asiatico , Bifidobacterium , Heces/microbiología , Tracto Gastrointestinal/microbiología , Hipersensibilidad Inmediata/microbiología , Fórmulas Infantiles/administración & dosificación , Lacticaseibacillus rhamnosus , Probióticos/administración & dosificación , Técnicas Bacteriológicas , Bacteroides/crecimiento & desarrollo , Bifidobacterium/genética , Bifidobacterium/crecimiento & desarrollo , Clostridium/crecimiento & desarrollo , ADN Bacteriano/análisis , Método Doble Ciego , Enterobacteriaceae/crecimiento & desarrollo , Eubacterium/crecimiento & desarrollo , Femenino , Citometría de Flujo , Edad Gestacional , Humanos , Hibridación Fluorescente in Situ , Lactante , Recién Nacido , Lacticaseibacillus rhamnosus/genética , Lacticaseibacillus rhamnosus/crecimiento & desarrollo , Masculino , Reacción en Cadena de la Polimerasa , Prevotella/crecimiento & desarrollo , Medición de Riesgo , Factores de Riesgo , Factores de TiempoRESUMEN
Blomia tropicalis allergens are the most important mite allergens in tropical regions. Most of them only have 30-40% sequence identity with their Dermatophagoides counterparts and they share low IgE cross reactivity and exhibit different immunobiology. Unlike the pyroglyphid counterparts, Blo t 5 is the major allergen whereas Blo t 1 only has modest allergenicity.